PEPCID COMPLETE 165 MG
MAGNESIUM HYDROXIDE : 165 MG FAMOTIDINE : 10 MG CALCIUM CARBONATE : 800 MG · DIN 02243053 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is PEPCID COMPLETE?
PEPCID COMPLETE 165 MG contains MAGNESIUM HYDROXIDE : 165 MG FAMOTIDINE : 10 MG CALCIUM CARBONATE : 800 MG. It is listed in the Health Canada Drug Product Database under DIN 02243053, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET (CHEWABLE) for ORAL administration. Health Canada currently lists it as marketed, status dated 18-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PEPCID COMPLETE used for?
PEPCID® COMPLETE® (famotidine, calcium carbonate, magnesium hydroxide) is indicated for: • the treatment of the following conditions where neutralization of gastric acid and a controlled reduction of gastric secretion is required, such as acid indigestion, heartburn, sour or upset stomach; • the prevention of these symptoms when associated with the consumption of food and/or beverage PEPCID® COMPLETE® relieves and prevents daytime heartburn symptoms and relieves heartburn during the night.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02243053 |
|---|---|
| Brand name | PEPCID COMPLETE |
| Generic / active ingredient | MAGNESIUM HYDROXIDE : 165 MG FAMOTIDINE : 10 MG CALCIUM CARBONATE : 800 MG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 165 MG |
| Dosage form | TABLET (CHEWABLE) |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02BA53 FAMOTIDINE, COMBINATIONS |
| AHFS class | 56:28.12 ; 56:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Dec-2025 |
| Original market date | 2001-05-14 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Bottles of 25 and 50 (mint flavour), Bottles of 25 (berry flavour)
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.